Pricing Log in Create free account

Abpro Holdings Inc. (ABPO) vs Oragenics, Inc. (OGEN)

Abpro Holdings Inc. and Oragenics, Inc. are both Biotechnology companies. Oragenics, Inc. is the larger, with a market value of $1.6M against $1.4M — 1.1× the size. Oragenics, Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.5×. Across the 7 metrics below, Abpro Holdings Inc. leads on 6 and Oragenics, Inc. on 1.

Valuation

Metric ABPO OGEN Biotechnology median
P/E 0.55 n/m 10.60
P/S n/m 12.53 9.40
P/B n/m 0.42 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 n/m 0.66
EV/Sales n/m 0.69 9.02
Earnings yield 183.50% (982.63%) (32.88%)
Free cash flow yield (193.29%) (656.98%) (23.13%)

Profitability

Metric ABPO OGEN Biotechnology median
Gross margin — 19.89% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) (1,307.07%) (51.96%)
Return on assets 46.10% (264.23%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO OGEN Biotechnology median
Revenue growth (TTM) — (75.08%) 6.76%
EPS growth (last fiscal year) 94.15% 90.51% 29.88%
Revenue growth, 5-year CAGR — (50.98%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO OGEN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 3.01 4.97
Net debt to EBITDA 0.01 0.98 1.01

Dividend

Metric ABPO OGEN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABPO OGEN Biotechnology median
Market cap 1.42m 1.58m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack